Hello, everyone, and welcome to GBDC's earnings call for the fiscal quarter ended March 31, 2026. Before we begin, I'd like to take a moment to remind our listeners that remarks made during this call ...

Q1 2026 sees Canadian apparel split between digitally savvy growth leaders and legacy retailers facing restructuring, ...

Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2026. The full report can be ...

More creators are combining structured collaboration systems with trust-focused monetization frameworks to grow their brands while protecting audience credibility. From celebrity live-stream ...

Infrastructure is a core piece of the durable income investor's puzzle. It has the potential to produce high recurrent ...

Discover the crucial steps for founders aiming to build a successful luxury brand, emphasizing long-term vision, identity, ...

Over the past 18 months, a steady stream of shutdowns has cut across early stage AI startups, raising questions about whether the country’s AI moment is overhyped. However, a closer examination of the ...

HIGHLIGHTS Outstanding infill drilling results continue to establish the scale, grade and continuity of the +800m high-grade ...

The dearth of child-bearing in western countries like the US is seen as a political crisis. Yet, if there is any place in our ...

The government is set to completely overhaul indemnity health insurance, shifting its focus to coverage for severe illnesses and essential medical ...

After a hiatus of almost a decade, Teva has made a pipeline-building acquisition, buying Emalex Biosciences and its candidate ...